In order to provide an equitable process for all accredited CME providers within the ACCME system, the ACCME is assessing a per activity fee from accredited CME providers that receive commercial support from the REMS Program Companies (RPC) to develop ER/LA Opioid Analgesic REMS-compliant CE activities; this fee will enable ACCME to develop, implement, and maintain the systems required to support the data collection, reporting, and auditing process stipulated by the FDA. As of January 1, 2015, the per activity service fee is $500. To fulfill the FDA’s expectation that REMS not be a burden to CE providers and prescribers, the ACCME expects that the fees will be incorporated into the RPC commercial support grants to accredited providers. The fees will be paid to the ACCME by the accredited providers.
ACCME-accredited or state-accredited providers that are doing REMS activities that are not commercially-supported by the RPC are not subject to a fee. They may report REMS-specific activity data in PARS, and this data will be included in aggregate reporting that the ACCME completes as a service to the CME community. However, at this time, these activities will not be included in the REMS auditing process.